Sign in

CIK 0001130598

  • Non-accelerated filer
  • Smaller reporting company

Traws Pharma, Inc.

Sign in to watch
Ticker
TRAW
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 267-759-3680
Business address
12 PENNS TRAIL, NEWTOWN, PA, 18940
Former names
Onconova Therapeutics, Inc., ONCONOVA THERAPEUTICS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 26 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2015-09-25 BANSAL AJAY Chief Financial Officer Grant or award · Stock Option (right to purchase) +32,500 32,500
2015-09-25 MCKEARN THOMAS J President, R&D Grant or award · Stock Option (right to purchase) +37,500 37,500
2015-09-25 Guerin Mark Patrick Chief Accounting Officer Grant or award · Stock Option (right to purchase) +17,500 17,500
2015-09-25 Fruchtman Steven M Chief Medical Officer Grant or award · Stock Option (right to purchase) +40,000 40,000
2015-09-25 Maniar Manoj SVP - Product Development Grant or award · Stock Option (right to purchase) +40,000 40,000
2015-06-15 Hoffman Michael B Director Grant or award · Stock Option (right to purchase) +13,000 13,000
2015-06-15 Reddy E Premkumar Director Grant or award · Stock Option (right to purchase) +10,000 10,000
2015-06-15 GROOPMAN JEROME Director Grant or award · Stock Option (right to purchase) +10,000 10,000
2015-06-15 MEHTA VIREN Director Grant or award · Stock Option (right to purchase) +10,000 10,000
2015-06-15 Bienen Henry S Director Grant or award · Stock Option (right to purchase) +10,000 10,000
2015-06-15 VANLENT ANNE Director Grant or award · Stock Option (right to purchase) +10,000 10,000
2015-05-06 Baxter Healthcare SA 10% owner Other disposition −2,603,295 0
2015-04-20 Fruchtman Steven M Chief Medical Officer Grant or award · Stock Option (right to purchase) +35,000 35,000
2015-04-16 BANSAL AJAY Chief Financial Officer Grant or award · Stock Option (right to purchase) +32,500 32,500
2015-04-16 Guerin Mark Patrick Chief Accounting Officer Grant or award · Stock Option (right ot purchase) +15,000 15,000
2015-04-16 MCKEARN THOMAS J President, R&D Grant or award · Stock Option (right to buy) +37,500 37,500
2015-04-16 Kumar Ramesh President and CEO Grant or award · Stock Option (right to buy) +87,500 87,500
2014-12-18 Kumar Ramesh President and CEO Grant or award · Stock Option (right to purchase) +175,000 175,000
2014-12-18 BANSAL AJAY Chief Financial Officer Grant or award · Stock Option (right to purchase) +65,000 65,000
2014-12-18 MCKEARN THOMAS J President, R&D Grant or award · Stock Option (right to purchase) +75,000 75,000

Page 20 of 23 · 449 trades